Moderna (MRNA)

Operating Cash Flow Growth

42.76%

Quarterly · Period ending:

MRNA logo

MRNA Operating Cash Flow Growth

Year-over-year change vs the same period a year earlier

Latest reported42.76%
MRNA Quarterly Cash from Operations YoY % (-19.81% → 42.76%)
High-resolution chart · PNG

MRNA operating cash flow growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Moderna Operating Cash Flow Growth — Quarterly
Period endingOperating Cash Flow Growth
42.7639%
39.2478%
15.2727%
45.9132%
27.865%
-4.8534%
32.6367%
2.125%
-39.235%
19.2653%
-62.5752%
-734.9206%
-400.9868%
-144.3359%
-49.7885%
-92.3077%
-92.5178%
-7.001%
161.8072%
266.9569%
17,117.801%
2,897.7889%
1,420.0892%
933.9698%
78.7248%
26.2188%
-5.2219%
-33.458%
-132.5851%
-29.2158%
11.5684%
-88.2004%
48.1018%
-19.8094%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.